Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and at 9283

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with at 9283 in 3 studies

Compound Research Comparison

Studies
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Trials
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Recent Studies (post-2010)
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Studies
(at 9283)
Trials
(at 9283)
Recent Studies (post-2010) (at 9283)
6201423020

Protein Interaction Comparison

ProteinTaxonomy4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide (IC50)at 9283 (IC50)
Aurora kinase AHomo sapiens (human)0.4331
Tyrosine-protein kinase JAK2Homo sapiens (human)0.0014
Ribosomal protein S6 kinase alpha-4Homo sapiens (human)0.01
Tyrosine-protein kinase ABL1Homo sapiens (human)0.0055
Cyclin-dependent kinase 1Homo sapiens (human)1.7
Tyrosine-protein kinase YesHomo sapiens (human)0.001
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.001
Fibroblast growth factor receptor 1Homo sapiens (human)0.01
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.01
G2/mitotic-specific cyclin-B1Homo sapiens (human)1.7
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.01
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.01
Fibroblast growth factor receptor 2Homo sapiens (human)0.0055
Fibroblast growth factor receptor 3Homo sapiens (human)0.01
Non-receptor tyrosine-protein kinase TYK2Homo sapiens (human)0.001
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.001
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.01
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.01
Glycogen synthase kinase-3 betaHomo sapiens (human)0.001
Ribosomal protein S6 kinase alpha-3Homo sapiens (human)0.001
Tyrosine-protein kinase JAK3Homo sapiens (human)0.0011
Tyrosine-protein kinase MerHomo sapiens (human)0.001
Maternal embryonic leucine zipper kinaseHomo sapiens (human)0.685
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)0.01
Serine/threonine-protein kinase D1Homo sapiens (human)0.01
Ribosomal protein S6 kinase alpha-2Homo sapiens (human)0.001
Cyclin-dependent kinase-like 3Homo sapiens (human)1.1
Dual specificity tyrosine-phosphorylation-regulated kinase 2Homo sapiens (human)0.57
Aurora kinase BHomo sapiens (human)0.3046
Serine/threonine-protein kinase 17AHomo sapiens (human)0.01

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR1
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR1
Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR1

Other Studies

3 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and at 9283

ArticleYear
Highly predictive and interpretable models for PAMPA permeability.
    Bioorganic & medicinal chemistry, 2017, 02-01, Volume: 25, Issue:3

    Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine

2017
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
    Bioorganic & medicinal chemistry, 2019, 07-15, Volume: 27, Issue:14

    Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility

2019
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
    Scientific reports, 2020, 11-26, Volume: 10, Issue:1

    Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States

2020